Fortis Advisors LLC Increases Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Fortis Advisors LLC grew its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 12.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,950 shares of the exchange traded fund’s stock after purchasing an additional 650 shares during the period. Fortis Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $536,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Bank of New York Mellon Corp boosted its position in shares of SPDR S&P Biotech ETF by 15.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,590 shares of the exchange traded fund’s stock valued at $518,000 after acquiring an additional 744 shares during the last quarter. BOKF NA grew its stake in shares of SPDR S&P Biotech ETF by 65.5% in the 2nd quarter. BOKF NA now owns 1,390 shares of the exchange traded fund’s stock worth $129,000 after buying an additional 550 shares in the last quarter. Envestnet Asset Management Inc. raised its position in shares of SPDR S&P Biotech ETF by 12.5% during the 2nd quarter. Envestnet Asset Management Inc. now owns 186,400 shares of the exchange traded fund’s stock valued at $17,281,000 after buying an additional 20,685 shares in the last quarter. Greenwich Wealth Management LLC raised its position in shares of SPDR S&P Biotech ETF by 10.3% during the 2nd quarter. Greenwich Wealth Management LLC now owns 11,505 shares of the exchange traded fund’s stock valued at $1,067,000 after buying an additional 1,073 shares in the last quarter. Finally, Bcwm LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 4.2% in the 2nd quarter. Bcwm LLC now owns 42,915 shares of the exchange traded fund’s stock valued at $3,979,000 after acquiring an additional 1,742 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $89.13 on Tuesday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The business’s 50 day moving average is $95.28 and its two-hundred day moving average is $97.10. The stock has a market capitalization of $6.79 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.